BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Soulen MC. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. J Vasc Interv Radiol. 2015;26:1257-65; quiz 1265. [PMID: 25990133 DOI: 10.1016/j.jvir.2015.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Owen JM, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography. J Clin Imaging Sci. 2016;6:29. [PMID: 27563495 DOI: 10.4103/2156-7514.186510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Luo SH, Chu JG, Huang H, Yao KC. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2017;23:4779-4787. [PMID: 28765699 DOI: 10.3748/wjg.v23.i26.4779] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
3 Young S, Scanlon P, Sherestha P, Golzarian J, Sanghvi T. Duplex Ultrasound Versus Clinical Surveillance in the Prediction of TIPS Malfunction Placed for Refractory Ascites: Is Ultrasound Surveillance Useful? Cardiovasc Intervent Radiol 2017;40:1861-5. [DOI: 10.1007/s00270-017-1706-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Williams SK, Morris ME, Kosnik PE, Lye KD, Gentzkow GD, Ross CB, Dwevidi AJ, Kleinert LB. Point-of-Care Adipose-Derived Stromal Vascular Fraction Cell Isolation and Expanded Polytetrafluoroethylene Graft Sodding. Tissue Eng Part C Methods 2017;23:497-504. [PMID: 28657470 DOI: 10.1089/ten.TEC.2017.0105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Jalaeian H, Talaie R, D'Souza D, Taleb S, Noorbaloochi S, Flanagan S, Hunter D, Golzarian J. Minilaparotomy-Assisted Transmesenteric-Transjugular Intrahepatic Portosystemic Shunt: Comparison with Conventional Transjugular Approach. Cardiovasc Intervent Radiol 2016;39:1413-9. [PMID: 27272888 DOI: 10.1007/s00270-016-1385-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Li HB, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dong XQ, Liu FQ. Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy. Can J Gastroenterol Hepatol 2018;2018:4671590. [PMID: 30079331 DOI: 10.1155/2018/4671590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Perello MP, Mur JP, Vives MS, Riutort JMM, Artigues AP, Garcia CN, Vidal MLB, Gelabert AE, Garau MV. Long-term follow-up of transjugular intrahepatic portosystemic shunt (TIPS) with stent-graft. Diagn Interv Radiol 2019;25:346-52. [PMID: 31322502 DOI: 10.5152/dir.2019.18416] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
8 Maschke SK, Werncke T, Renne J, Kloeckner R, Marquardt S, Kirstein MM, Potthoff A, Wacker FK, Meyer BC, Hinrichs JB. Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction: quantitative assessment of flow and perfusion changes using 2D-perfusion angiography following shunt revision. Abdom Radiol 2018;43:2868-75. [DOI: 10.1007/s00261-018-1547-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Luo SH, Chu JG, Huang H, Zhao GR, Yao KC. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy. World J Gastroenterol. 2019;25:1088-1099. [PMID: 30862997 DOI: 10.3748/wjg.v25.i9.1088] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
10 Ahmed M, Keshava SN, Moses V, Chiramel GK, Mammen S, Eapen CE, Zachariah UG. Transjugular Intrahepatic Portosystemic Shunt Through the Strut of a Previously Placed Stent: Technical Feasibility and Long-Term Follow-Up Results. Cardiovasc Intervent Radiol 2018;41:1794-8. [PMID: 30014251 DOI: 10.1007/s00270-018-2033-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wan YM, Li YH, Xu ZY, Wu HM, Wu XN, Xu Y. Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding. Eur Radiol 2019;29:5032-41. [PMID: 30796573 DOI: 10.1007/s00330-019-06046-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Wan YM, Li YH, Xu Y, Wu HM, Li YC, Wu XN, Yang JH. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft. Acad Radiol 2018;25:925-34. [PMID: 29373208 DOI: 10.1016/j.acra.2017.11.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
13 Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment. J Clin Transl Hepatol. 2018;6:105-113. [PMID: 29577037 DOI: 10.14218/jcth.2017.00035] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
14 Zhang Y, Liu FQ, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL. Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study. World J Clin Cases 2019;7:1410-20. [PMID: 31363469 DOI: 10.12998/wjcc.v7.i12.1410] [Reference Citation Analysis]
15 Shen NT, Schneider Y, Congly SE, Rosenblatt RE, Namn Y, Fortune BE, Jesudian A, Brown RS. Cost Effectiveness of Early Insertion of Transjugular Intrahepatic Portosystemic Shunts for Recurrent Ascites. Clin Gastroenterol Hepatol. 2018;16:1503-1510.e3. [PMID: 29609068 DOI: 10.1016/j.cgh.2018.03.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
16 Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017;9:603-12. [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Zhao D, Zhang G, Wang M, Zhang C, Li J. Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt. Clin Mol Hepatol 2019;25:210-7. [PMID: 30897897 DOI: 10.3350/cmh.2018.0083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Dong F, Luo SH, Zheng LJ, Chu JG, Huang H, Zhang XQ, Yao KC. Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency. World J Clin Cases. 2019;7:2450-2462. [PMID: 31559281 DOI: 10.12998/wjcc.v7.i17.2450] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Li YH, Xu ZY, Wu HM, Yang LH, Xu Y, Wu XN, Wan YM. Long-term shunt patency and overall survival of transjugular intrahepatic portosystemic shunt placement using covered stents with bare stents versus covered stents alone. Clin Radiol. 2018;73:580-587. [PMID: 29475551 DOI: 10.1016/j.crad.2018.01.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
20 Chen SL, Xiao CJ, Wang S, Jin SY, Zhao JB. The Pull-Through Technique for Recanalization of Transjugular Intrahepatic Portosystemic Shunt Dysfunction. Gastroenterol Res Pract 2020;2020:9150173. [PMID: 32411208 DOI: 10.1155/2020/9150173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Geeroms B, Laleman W, Laenen A, Heye S, Verslype C, van der Merwe S, Nevens F, Maleux G. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results. Eur Radiol 2017;27:1795-803. [PMID: 27629421 DOI: 10.1007/s00330-016-4570-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
22 Cam I, Gencturk M, Shrestha P, Golzarian J, Flanagan S, Lim N, Young S. Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement. AJR Am J Roentgenol 2021;216:1291-9. [PMID: 32755214 DOI: 10.2214/AJR.20.23846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Qiu B, Zhao MF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dai S, Yao JN, Liu FQ. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World J Gastroenterol. 2015;21:12439-12447. [PMID: 26604651 DOI: 10.3748/wjg.v21.i43.12439] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
24 Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2018;. [PMID: 29973706 DOI: 10.1038/s41395-018-0185-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]